Literature DB >> 21918051

Hepatic gas: widening spectrum of causes detected at CT and US in the interventional era.

Priti A Shah1, Steven C Cunningham, Tara A Morgan, Barry D Daly.   

Abstract

The spectrum of causes of hepatic gas detected at computed tomography (CT) and ultrasonography (US) is widening. There are many iatrogenic and noniatrogenic causes of hepatic parenchymal, biliary, hepatic venous, and portal venous gas. Hepatic gas may be an indicator of serious acute disease (infarct, infection, abscess, bowel inflammation, or trauma). In other clinical scenarios, it may be an expected finding related to therapeutic interventions (such as surgery; hepatic artery embolization for a tumor or for active bleeding in acute trauma cases; percutaneous tumor ablation performed with radiofrequency, cryotherapy, laser photocoagulation, or ethanol). In some cases, hepatic gas is an incidental finding of no clinical significance. Familiarity with the expanding list of newer intervention-related causes of hepatic gas detected at CT and US, knowledge of the patient's clinical history, and a careful search for associated clues on images are all factors that may allow the radiologist to better determine the clinical relevance of this finding.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21918051     DOI: 10.1148/rg.315095108

Source DB:  PubMed          Journal:  Radiographics        ISSN: 0271-5333            Impact factor:   5.333


  11 in total

Review 1.  Prevention and management of infectious complications of percutaneous interventions.

Authors:  Steven Y Huang; Asher Philip; Michael D Richter; Sanjay Gupta; Mark L Lessne; Charles Y Kim
Journal:  Semin Intervent Radiol       Date:  2015-06       Impact factor: 1.513

2.  Extensive portal venous gas in a post-operative patient with no identifiable cause.

Authors:  Adam Hussein; Rohit Makhija
Journal:  J Surg Case Rep       Date:  2015-10-29

3.  Rapid Emergency Medicine Score: A novel prognostic tool for predicting the outcomes of adult patients with hepatic portal venous gas in the emergency department.

Authors:  Chen-June Seak; David Hung-Tsang Yen; Chip-Jin Ng; Yon-Cheong Wong; Kuang-Hung Hsu; Joanna Chen-Yeen Seak; Hsien-Yi Chen; Chen-Ken Seak
Journal:  PLoS One       Date:  2017-09-15       Impact factor: 3.240

Review 4.  Posttraumatic venous gas in the liver - a case report and review of the current literature.

Authors:  René Fahrner; Falk Rauchfuss; Hubert Scheuerlein; Utz Settmacher
Journal:  BMC Surg       Date:  2018-03-02       Impact factor: 2.102

5.  Sonographic findings of hepatic venous gas in association with spontaneous rupture of a Klebsiella pneumoniae liver abscess: a case report.

Authors:  Haining Zheng; Chenxing Gu; Suzhen Jiang; Xiaona Liu; Xiaoqing Wang; Chaoyang Wen
Journal:  J Int Med Res       Date:  2021-03       Impact factor: 1.671

6.  Conservative treatment of hepatic portal venous gas consecutive to a complicated diverticulitis: A case report and literature review.

Authors:  Alexandre Moser; Anita Stauffer; André Wyss; Claudio Schneider; Manfred Essig; Alexander Radke
Journal:  Int J Surg Case Rep       Date:  2016-04-30

7.  Hepatic portal venous gas after colonoscopy: A case report and review.

Authors:  G T Capolupo; G Mascianà; F Carannante; M Caricato
Journal:  Int J Surg Case Rep       Date:  2018-07-21

8.  Computed Tomographic Characterization of Traumastem-A New Oxidized Cellulose Hemostatic Agent.

Authors:  Paul B Lewis; Scott T Wilson; Dustin R Kentala; John Barry; Kevin M Lewis
Journal:  Tomography       Date:  2016-09

9.  Clinical features of patients with hepatic portal venous gas.

Authors:  Manato Fujii; Suguru Yamashita; Mayuko Tanaka; Jo Tashiro; Yoshiharu Takenaka; Kazuki Yamasaki; Yukiyoshi Masaki
Journal:  BMC Surg       Date:  2020-11-27       Impact factor: 2.102

10.  A case report of fatal hepatic portal venous gas after transcatheter arterial chemoembolization in a patient with hepatocellular carcinoma.

Authors:  Lichao Xu; Ying Wang; Wentao Li
Journal:  Transl Cancer Res       Date:  2021-12       Impact factor: 1.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.